In Case 1 ( 18 ), with a decreasing trend in IL-6 levels after treatment initiation, we speculated that on day 18, both platelet destruction and production were balanced in a hyperactive state with elevated IL-6, and on day 82, both were balanced at a low level with normalized IL-6.
← all excerpts
Clinical Utility of an Increased Pretreatment Immature Platelet Fraction in the Early Diagnosis of TAFRO Syndrome, Especially in Patients with Late-onset Thrombocytopenia: A Case Series and Literature Review.
1
—
—